FimmCyte AG
Biotechnology · Basel, Basel-Stadt
FimmCyte AG is a Swiss biotechnology company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2022 (UID CHE-174.194.506).
Board members & signatories
- Dr. Markus Kalousek — Präsident des Verwaltungsrates
- Dr. Mohaned Shilaih — Mitglied des Verwaltungsrates
Registered purpose
Der Zweck der Gesellschaft ist die Erbringung von Dienstleistungen in den Bereichen Forschung, Entwicklung, Herstellung, Registrierung, Förderung, Vermarktung sowie der Handel von Produkten in den Gebieten der Informationstechnologie, Biotechnologie, Pharmazie, Medizintechnologie, Diagnose und Therapie. Die Gesellschaft bezweckt ferner den Erwerb, Archivierung, Nutzung und kommerzielle Verwertung …
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What FimmCyte does
OFFERING
FimmCyte AG develops targeted immunotherapy solutions aimed at treating endometriosis and other chronic fibro-inflammatory diseases. Their primary product, FMC, is designed to eliminate diseased tissue while preserving healthy areas, addressing critical unmet needs in women's health.
Unlock the full analysis →Similar companies
- Stromal Therapeutics AG — Biotechnology · Basel
- Immitra Bio GmbH — Biotechnology · Plan-les-Ouates
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- Seito Biologics AG — Biotechnology · Küsnacht ZH
- Immunocore GmbH — Biotechnology · Rotkreuz
- Cimeio Therapeutics AG — Pharmaceuticals · Basel
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime